Method of solubilizing poorly soluble/insoluble active material through formation of oligomer composite

Abstract
Provided is a method of solubilizing a poorly soluble/insoluble active material through formation of an oligomer composite, in which a structure having a hydrophobic cavity structure is formed by using oligomers derived from two types of hydrophilic natural polymers and a poorly soluble/insoluble component is encapsulated in the cavity structure, and thus, self-aggregation of the poorly soluble/insoluble material is prevented and simultaneously, thermodynamic stability increases to effectively solubilize the poorly soluble/insoluble material. According to the constitution of the present invention, the method may include a first operation of preparing an oligomer composite having a cavity structure formed therein by mixing and dissolving oligomers derived from two types of hydrophilic natural polymers in water, and a second operation of adding a poorly soluble/insoluble material to the oligomer composite to encapsulate the poorly soluble/insoluble material in the hydrophobic cavity structure of the oligomer composite.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a national stage filing of International Application No. PCT/KR2010/007066 which claims priority under 35 U.S.C. 119 and 35 U.S.C. 365 to Korean Patent Application No. 10-2009-0121886 filed on Dec. 9, 2009, which is hereby incorporated by reference in its entirety.


BACKGROUND

The present disclosure relates to a method of solubilizing a poorly soluble/insoluble active material through formation of an oligomer composite, in which a structure having a hydrophobic cavity structure is formed by using oligomers derived from two types of hydrophilic natural polymers and a poorly soluble/insoluble component is encapsulated in the cavity structure, and thus, self-aggregation of the poorly soluble/insoluble material is prevented and simultaneously, thermodynamic stability increases to effectively solubilize the poorly soluble/insoluble material.


Recently, development of natural ingredients having excellent biocompatibility and biostability as well as excellent biological activity with respect to the human body has become more important in discovering biologically active substances in cosmetics, food, and medicine industries. However, some natural ingredients are unstable under an acidic condition or others are unstable under a basic condition. That is, characteristics of the active ingredients are overall different and methods of sufficiently stabilizing active ingredients in a formulation are still in a development stage.


Therefore, natural ingredients currently having high efficacy and effect are expected to have a large potential value, but about 40% of the foregoing natural ingredients are not even in a development stage due to its low solubility. A process of increasing solubility of such a material poorly soluble in water or an aqueous solution by a certain manipulation is denoted as “solubilization”. A typical technique able to improve solubility and increase absorption of drugs may include a method of using an organic solvent, such as ethanol, or surfactant as an additive, a method of preparing as a salt form when an ionization group is contained, and a method of increasing solubility by adjusting a pH, etc.


Recently, various attempts have also been made to improve typical limitations of poorly soluble/insoluble materials by introducing liposome, microemulsion, cyclodextrin, and nanopowder techniques to solubilize the poorly soluble/insoluble materials.


SUMMARY OF THE INVENTION

Embodiments provide a method of solubilizing a poorly soluble/insoluble active material through formation of an oligomer composite, in which a structure having a hydrophobic cavity structure is formed by using oligomers derived from two types of hydrophilic natural polymers and a poorly soluble/insoluble component is encapsulated in the cavity structure, and thus, self-aggregation of the poorly soluble/insoluble material is prevented and thermodynamic stability increases to effectively solubilize the poorly soluble/insoluble material.


The technical objects of the present disclosure are not limited to the aforesaid, but other technical objects not described herein will be clearly understood by those skilled in the art from descriptions below.


In one embodiment, a method of solubilizing a poorly soluble/insoluble active material through formation of an oligomer composite includes: a first operation of preparing an oligomer composite having a cavity structure formed therein by mixing and dissolving oligomers derived from two types of hydrophilic natural polymers in water; and a second operation of adding a poorly soluble/insoluble material to the oligomer composite to encapsulate the poorly soluble/insoluble material in the hydrophobic cavity structure of the oligomer composite.


In another embodiment, the method may further include, after the second operation: a third operation of removing a residual poorly soluble/insoluble material unencapsulated in the oligomer composite by filtration or centrifugation of a reaction solution; and a fourth operation of removing water and an organic solvent (when used) from the reaction solution having the residual material removed therefrom to dry.


The details of one or more embodiments are set forth in the accompanying drawings and the description below. Other features will be apparent from the description and drawings, and from the claims.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates a structure, in which a poorly soluble/insoluble material is encapsulated in a cavity structure of an oligomer composite of the present invention.





DETAILED DESCRIPTION OF THE EMBODIMENTS

Reference will now be made in detail to the embodiments of the present disclosure, examples of which are illustrated in the accompanying drawings.


A basic concept of the present invention is that when poorly soluble/insoluble materials are encapsulated in an oligomer composite having a hydrophobic cavity structure, precipitation of poorly soluble/insoluble components in an aqueous solution is prevented by preventing aggregation and re-aggregation of the poorly soluble/insoluble components, dissolution stability is improved such that a chemical reaction able to change a structure of the poorly soluble/insoluble components is not accompanied, and these components are encapsulated in an oligomer structure having a cavity structure physically formed therein to maintain an inherent natural biological activity as it is.


A method of preparing an oligomer composite according to the present invention includes: a first operation of preparing an oligomer composite having a physical cavity structure formed therein by mixing and dissolving oligomers derived from two types of hydrophilic natural polymers in water; and a second operation of adding a poorly soluble/insoluble material to the oligomer composite to encapsulate the poorly soluble/insoluble material in the hydrophobic cavity structure of the oligomer composite.


Two natural polymer oligomers are selected from the group consisting of xanthan gum, acacia gum, guar gum, arabic gum, agar, alginic acid, chitosan, pectin, carboxyalkylcellulose, maltodextrin, dextrin, and hyaluronic acid, and then mixed.


Each weight ratio of two types of the selected natural polymer oligomers with respect to distilled water is in a range of 1:1 to 1:10 and in particular, may be in a range of 1:2 to 1:4. At this time, when the weight ratio of one natural polymer oligomer among the two types of natural polymer oligomers is too high, an encapsulation effect of a poorly soluble/insoluble active component may decrease because the hydrophobic cavity structure of the oligomer structure may not be properly formed.


Also, a weight ratio between the two types of natural polymer oligomers and water is in a range of 1:1 to 1:100. When the weight ratio of the natural polymer oligomers with respect to the water is too high, preparation of an oligomer composite solution may be difficult because viscosity of the solution may be excessively increased by the natural polymer oligomers. On the other hand, when the weight ratio of the natural polymer oligomers with respect to the water is too low, the encapsulation effect of the poorly soluble/insoluble active component may decrease because the hydrophobic cavity structure may not be properly formed due to a relatively low physical bonding force between molecules of the oligomer composite in the aqueous solution. An average molecular weight of the natural polymer oligomer used may be in a range of 1,000 to 100,000.


Also, a preparation temperature during the preparation of the oligomer composite may be within a range of 20° C. to 80° C., and in particular, the oligomer composite may be prepared within a temperature range of 40° C. to 50° C. At this time, a pH of the solution may be maintained in a range of 5 to 8. When the pH and temperature during the preparation of the oligomer composite are not controlled, the hydrophobic cavity structure may not be properly formed, because the physical bonding force between the molecules of the oligomer composite may decrease.


Meanwhile, in the second operation of adding a poorly soluble/insoluble material to the oligomer composite to encapsulate the poorly soluble/insoluble material in the hydrophobic cavity structure of the oligomer composite, the poorly soluble/insoluble material may be simply added or may be added by being dissolved in an organic solvent or the like. The poorly soluble/insoluble material is slowly added to the oligomer composite solution formed in the first operation in an amount range of 0.1 wt % to 99 wt % based on a total solid content. At this time, the poorly soluble/insoluble material may be added in an amount range of 1 wt % to 20 wt %. When the poorly soluble/insoluble material is added in an amount more than 99 wt %, an effect of improving solubility of the poorly soluble/insoluble component may decrease, because it deviates from the capacity limit of the hydrophobic cavity structure in the oligomer composite which may encapsulate the poorly soluble/insoluble component.


When the poorly soluble/insoluble material is added in the second operation, an appropriate temperature is within a range of 20° C. to 80° C., and the poorly soluble/insoluble material may be mixed and stirred within a temperature range of 40° C. to 50° C. At this time, an appropriate pH is in a range of 5 to 8 and the pH may be maintained in a range of 6.5 to 7.5. When the temperature and pH are not controlled, the poorly soluble/insoluble active component may not be properly encapsulated in the oligomer composite, because the hydrophobic cavity structure may collapse due to a decrease in the physical bonding force between the natural polymer oligomers constituting the oligomer composite.


Also, the organic solvent may be selected from the group consisting of methanol, ethanol, acetone, tetrahydrofuran (THF), and acetonitrile (AN).


The poorly soluble/insoluble materials may be selected from the group consisting of polyphenols, such as amentoflavone, ellagic acid, apigenin, berginin, diosmetin, univestin, resveratrol, isoflavones, and catechin, oily fatty acids, such as salicylic acid, alpha lipoic acid, caffeine, tocopherol, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and conjugated linolenic acid (CLA), and natural extracts containing a ginkgo biloba leaf extract, a red ginseng extract, and polyphenols.


Meanwhile, after the second operation, the method may further include a third operation of removing a residual poorly soluble/insoluble material unencapsulated in the oligomer composite by filtration or centrifugation of a reaction solution and a fourth operation of removing water and an organic solvent (when used) from the reaction solution having the residual material removed therefrom to dry.


The poorly soluble/insoluble materials are introduced to the oligomer composite having the cavity structure to increase the solubility of the poorly soluble/insoluble components and thus, dissolution stability may be improved.


In the present invention, interaction between the two types of natural polymer oligomers is used to form the oligomer composite having hydrophobic cavities and thus, structural density and physical bonding strength may increase. Therefore, the solubility is improved by encapsulating a material having poorly soluble/insoluble characteristics by physical bonding. [see FIG.1]


Hereinafter, the present invention will be described in detail, according to specific examples. However, the following examples are merely presented to exemplify the present invention, and the scope of the present invention is not limited thereto.


CONTROL GROUP EXAMPLES 1 TO 12

One type of natural polymer oligomers was selected and added to 156 g of distilled water according to a ratio of the following Table 1. A reaction temperature was maintained in a range of 40° C. to 50° C., a pH was maintained in a range of 5 to 8 by using a pH adjuster, and an oligomer aqueous solution was formed by being stirred until the oligomer was completely dissolved.


The temperature and pH of the formed oligomer aqueous solution were maintained in ranges of 40° C. to 50° C. and 6.5 to 7.5, respectively. An ellagic acid was used as a representative poorly soluble/insoluble material and a predetermined amount of the ellagic acid was slowly added to the oligomer aqueous solution. The ellagic acid was mixed and stirred within a temperature range of 40° C. to 50° C. At this time, the pH was maintained in a range of 6.5 to 7.5 to allow the ellagic acid to be completely mixed in the oligomer aqueous solution. The prepared aqueous solution was centrifuged and filtered to measure an amount of precipitates, and a filtrate was powdered by using a freeze dryer to prepare a control group.












TABLE 1







Use amount of
Use amount



Natural polymer from
natural polymer
of ellagic


Control Group
which oligomer is
derived oligomer
acid


Example
derived
(g)
(g)







Control Group
Maltodextrin
40
4


Example 1


Control Group
Dextrin
40
4


Example 2


Control Group
Guar gum
40
4


Example 3


Control Group
Arabic gum
40
4


Example 4


Control Group

Acacia gum

40
4


Example 5


Control Group
Alginic acid
40
4


Example 6


Control Group
Chitosan
40
4


Example 7


Control Group
Carboxymeth-
40
4


Example 8
ylcellulose


Control Group
Pectin
40
4


Example 9


Control Group
Agar
40
4


Example 10


Control Group
Xanthan gum
40
4


Example 11


Control Group
Hyaluronic acid
40
4


Example 12









[Experimental Method for Evaluating Solubility and Dissolution Stability of Control Group]


The ellagic acid was added to the solutions having the natural polymer oligomers dissolved therein and mixed during the preparation of the powders of control group in Control Group Examples 1 to 12, and then the precipitates were dried during centrifugation to measure weights of insoluble precipitates.


The prepared powders of the control group were weighed and put into distilled water to make a volume of 100 ml, and aqueous solutions were then prepared by stirring for 30 minutes. The prepared aqueous solutions were put into centrifuge tubes, in which the weights thereof had been previously measured, and centrifuged. Filtrates were removed and the tubes were dried in a vacuum drier at 60° C. for five days, and amounts of precipitates were then measured by measuring weight changes and solubilities of the oligomer composites containing a poorly soluble/insoluble material with respect to water were calculated. The presence of precipitates were visually observed while the centrifuged supernatants were stored at 4° C. for zero week, one week, two weeks, three weeks, and four weeks.


The result of improvements in the solubility of poorly soluble/insoluble material and the presence of precipitates with respect to control group examples are presented in Table 2.
















TABLE 2








Input









amount of









powders








Precipitate
of








amount
control
Precipitate






Poorly
during
group
amount





Control
soluble/
preparation
during
during





Group
insoluble
of control
redissolution
redissolution
Solubility
Storage
Presence of


Example
material
group (g)1)
(g)
(g)
(mg/ml)
period
precipitate2)







Control
Ellagic
1.90
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example 1









Control
Ellagic
1.90
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example 2









Control
Ellagic
1.95
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example 3









Control
Ellagic
1.94
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example 4









Control
Ellagic
1.95
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example 5









Control
Ellagic
1.93
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example 6









Control
Ellagic
1.95
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example 7









Control
Ellagic
1.96
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example 8









Control
Ellagic
1.95
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example 9









Control
Ellagic
1.92
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example









10









Control
Ellagic
1.90
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example









11









Control
Ellagic
1.91
2.0
0.0
20.0
4 weeks
Occurred in


Group
acid





one week


Example









12






1)precipitate amount of ellagic acid undissolved during the preparation of single oligomer composite containing an ellagic acid




2)storage period of 4 weeks at 4° C., observation of the presence of precipitate







As shown in the result of Table 2, with respect to the control group examples in which single natural polymer oligomer was used, it may be understood that most of ellagic acid were precipitated instead of being unencapsulated in the single natural polymer oligomer during the oligomer powders containing the ellagic acid were dissolved in water and centrifuged. In order to investigate whether or not the solubilities were improved, the powders of the control group were redissolved and centrifuged, and then weights of precipitates were measured. As a result, the precipitates were not confirmed, but a residual ellagic acid was precipitated in one week when the centrifuged supernatant was stored at 4° C. and thus, it may be understood that the control group did not affect the improvement of the solubility of poorly soluble/insoluble component and the dissolution stability.


EXAMPLES 1 TO 120
Application of Oligomer Derived from Natural Polymer

Two types of natural polymer oligomers were mixed and added to 156 g of distilled water according to a ratio of the following Tables 3 to 5. A reaction temperature was maintained in a range of 40° C. to 50° C., a pH was maintained in a range of 5 to 8 by using a pH adjuster, and an oligomer composite solution was formed by stirring until the oligomers were completely dissolved.


Temperature and pH of the formed oligomer composite solution were maintained in ranges of 40° C. to 50° C. and 6.5 to 7.5, respectively. An ellagic acid was used as a representative poorly soluble/insoluble material and a predetermined amount of the ellagic acid was slowly added to the oligomer composite solution. The ellagic acid was mixed and stirred within a temperature range of 40° C. to 50° C. At this time, the pH was maintained in a range of 6.5 to 7.5 to allow the ellagic acid to be encapsulated in the hydrophobic cavity structure of the oligomer composite. The reaction solution was centrifuged and filtered to measure weight of the unencapsulated and removed ellagic acid, and a supernatant or filtrate was powdered by using a freeze dryer to prepare an ellagic acid encapsulated oligomer composite.













TABLE 3









Use






amount






of




Natural polymer from
Use
ellagic




which oligomer is
amount
acid



Example
derived
(g)
(g)








Example 1
Xanthan gum
10
4




Maltodextrin
30




Example 2
Xanthan gum
10
4




Dextrin
30




Example 3
Xanthan gum
10
4




Guar gum
30




Example 4
Xanthan gum
10
4




Arabic gum
30




Example 5
Xanthan gum
10
4





Acacia gum

30




Example 6
Xanthan gum
10
4




Alginic acid
30




Example 7
Xanthan gum
10
4




Chitosan
30




Example 8
Xanthan gum
10
4




Carboxymethylcellulose
30




Example 9
Xanthan gum
10
4




Pectin
30




Example
Xanthan gum
10
4



10
Agar
30




Example
Maltodextrin
10
4



11
Xanthan gum
30




Example
Maltodextrin
10
4



12
Dextrin
30




Example
Maltodextrin
10
4



13
Guar gum
30




Example
Maltodextrin
10
4



14
Arabic gum
30




Example
Maltodextrin
10
4



15

Acacia gum

30




Example
Maltodextrin
10
4



16
Alginic acid
30




Example
Maltodextrin
10
4



17
Chitosan
30




Example
Maltodextrin
10
4



18
Carboxymethylcellulose
30




Example
Maltodextrin
10
4



19
Pectin
30




Example
Maltodextrin
10
4



20
Agar
30




Example
Dextrin
10
4



21
Maltodextrin
30




Example
Dextrin
10
4



22
Xanthan gum
30




Example
Dextrin
10
4



23
Guar gum
30




Example
Dextrin
10
4



24
Arabic gum
30




Example
Dextrin
10
4



25

Acacia gum

30




Example
Dextrin
10
4



26
Alginic acid
30




Example
Dextrin
10
4



27
Chitosan
30




Example
Dextrin
10
4



28
Carboxymethylcellulose
30




Example
Dextrin
10
4



29
Pectin
30




Example
Dextrin
10
4



30
Agar
30




Example
Guar gum
10
4



31
Maltodextrin
30




Example
Guar gum
10
4



32
Dextrin
30




Example
Guar gum
10
4



33
Xanthan gum
30




Example
Guar gum
10
4



34
Arabic gum
30




Example
Guar gum
10
4



35

Acacia gum

30




Example
Guar gum
10
4



36
Alginic acid
30




Example
Guar gum
10
4



37
Chitosan
30




Example
Guar gum
10
4



38
Carboxymethylcellulose
30




Example
Guar gum
10
4



39
Pectin
30




Example
Guar gum
10
4



40
Agar
30




Example
Arabic gum
10
4



41
Maltodextrin
30




Example
Arabic gum
10
4



42
Dextrin
30




Example
Arabic gum
10
4



43
Guar gum
30




Example
Arabic gum
10
4



44
Xanthan gum
30




Example
Arabic gum
10
4



45

Acacia gum

30




Example
Arabic gum
10
4



46
Alginic acid
30




Example
Arabic gum
10
4



47
Chitosan
30




Example
Arabic gum
10
4



48
Carboxymethylcellulose
30




















TABLE 4









Use






amount






of




Natural polymer from
Use
ellagic




which oligomer is
amount
acid



Example
derived
(g)
(g)








Example
Arabic gum
10
4



49
Pectin
30




Example

Acacia gum

10
4



50
Maltodextrin
30




Example

Acacia gum

10
4



51
Dextrin
30




Example

Acacia gum

10
4



52
Guar gum
30




Example

Acacia gum

10
4



53
Arabic gum
30




Example

Acacia gum

10
4



54
Xanthan gum
30




Example

Acacia gum

10
4



55
Alginic acid
30




Example

Acacia gum

10
4



56
Chitosan
30




Example

Acacia gum

10
4



57
Carboxymethylcellulose
30




Example

Acacia gum

10
4



58
Pectin
30




Example

Acacia gum

10
4



59
Agar
30




Example
Alginic acid
10
4



60
Maltodextrin
30




Example
Alginic acid
10
4



61
Dextrin
30




Example
Alginic acid
10
4



62
Guar gum
30




Example
Alginic acid
10
4



63
Arabic gum
30




Example
Alginic acid
10
4



64

Acacia gum

30




Example
Alginic acid
10
4



65
Xanthan gum
30




Example
Alginic acid
10
4



66
Chitosan
30




Example
Alginic acid
10
4



67
Carboxymethylcellulose
30




Example
Alginic acid
10
4



68
Pectin
30




Example
Alginic acid
10
4



69
Agar
30




Example
Chitosan
10
4



70
Maltodextrin
30




Example
Chitosan
10
4



71
Dextrin
30




Example
Chitosan
10
4



72
Guar gum
30




Example
Chitosan
10
4



73
Arabic gum
30




Example
Chitosan
10
4



74

Acacia gum

30




Example
Chitosan
10
4



75
Alginic acid
30




Example
Chitosan
10
4



76
Xanthan gum
30




Example
Chitosan
10
4



77
Carboxymethylcellulose
30




Example
Chitosan
10
4



78
Pectin
30




Example
Chitosan
10
4



79
Agar
30




Example
Carboxymethylcellulose
10
4



80
Maltodextrin
30




Example
Carboxymethylcellulose
10
4



81
Dextrin
30




Example
Carboxymethylcellulose
10
4



82
Guar gum
30




Example
Carboxymethylcellulose
10
4



83
Arabic gum
30




Example
Carboxymethylcellulose
10
4



84

Acacia gum

30




Example
Carboxymethylcellulose
10
4



85
Alginic acid
30




Example
Carboxymethylcellulose
10
4



86
Chitosan
30




Example
Carboxymethylcellulose
10
4



87
Xanthan gum
30




Example
Carboxymethylcellulose
10
4



88
Pectin
30




Example
Carboxymethylcellulose
10
4



89
Agar
30




Example
Pectin
10
4



90
Maltodextrin
30




Example
Pectin
10
4



91
Dextrin
30




Example
Pectin
10
4



92
Guar gum
30




Example
Pectin
10
4



93
Arabic gum
30




Example
Pectin
10
4



94

Acacia gum

30




Example
Pectin
10
4



95
Alginic acid
30




Example
Pectin
10
4



96
Chitosan
30




















TABLE 5









Use






amount






of




Natural polymer from
Use
ellagic




which oligomer is
amount
acid



Example
derived
(g)
(g)








Example
Pectin
10
4



97
Carboxymethylcellulose
30




Example
Pectin
10
4



98
Xanthan gum
30




Example
Pectin
10
4



99
Agar
30




Example
Agar
10
4



100
Maltodextrin
30




Example
Agar
10
4



101
Dextrin
30




Example
Agar
10
4



102
Guar gum
30




Example
Agar
10
4



103
Arabic gum
30




Example
Agar
10
4



104

Acacia gum

30




Example
Agar
10
4



105
Alginic acid
30




Example
Agar
10
4



106
Chitosan
30




Example
Agar
10
4



107
Carboxymethylcellulose
30




Example
Agar
10
4



108
Pectin
30




Example
Agar
10
4



109
Xanthan gum
30




Example
Hyaluronic acid
10
4



110
Maltodextrin
30




Example
Hyaluronic acid
10
4



111
Dextrin
30




Example
Hyaluronic acid
10
4



112
Guar gum
30




Example
Hyaluronic acid
10
4



113
Arabic gum
30




Example
Hyaluronic acid
10
4



114

Acacia gum

30




Example
Hyaluronic acid
10
4



115
Alginic acid
30




Example
Hyaluronic acid
10
4



116
Chitosan
30




Example
Hyaluronic acid
10
4



117
Carboxymethylcellulose
30




Example
Hyaluronic acid
10
4



118
Pectin
30




Example
Hyaluronic acid
10
4



119
Agar
30




Example
Hyaluronic acid
10
4



120
Xanthan gum
30









EXAMPLES 121 TO 138
Preparation of Oligomer Composite Containing Poorly Soluble/Insoluble Material

Dextrin and maltodextrin among natural polymer oligomers were added to distilled water according to a constant ratio as in the following Table 6. A reaction temperature was maintained in a range of 40° C. to 50° C., a pH was maintained in a range of 5 to 8 by using a pH adjuster, and an oligomer composite solution was formed by being stirred until the dextrin and maltodextrin were completely dissolved. The temperature and pH of the formed oligomer composite solution were maintained in ranges of 40° C. to 50° C. and 6.5 to 7.5, respectively. A predetermined amount of a poorly soluble/insoluble material was simply added to the oligomer composite solution or dissolved in an organic solvent to obtain a concentration of 1% to 50% and then the mixture was slowly added to the oligomer composite solution so as to allow the poorly soluble/insoluble material to be encapsulated in a hydrophobic cavity structure of the oligomer composite solution. The reaction solution was centrifuged and filtered to measure the weight of the unencapsulated and removed poorly soluble/insoluble material, an organic solvent such as ethanol was distilled by using a distiller for experimental groups including the organic solvent, and a supernatant or filtrate was powdered by using a freeze dryer to prepare an oligomer composite containing the poorly soluble/insoluble material.














TABLE 6









Added amount of






Name of poorly
poorly
Use amount



Use amount
Use amount of
soluble/insoluble
soluble/insoluble
of distilled


Category
of dextrin (g)
maltodextrin (g)
material
material (g)
water (g)




















Example 121
10
30
Amentoflavone
4
156


Example 122
10
30
Diosmetin
4
156


Example 123
10
30
Berginin
10
150


Example 124
10
30
Univestin
8
152


Example 125
10
30
Apigenin
4
156


Example 126
10
30
Resveratrol
4
156


Example 127
10
30
Isoflavones
8
152


Example 128
10
30
Salicylic acid
10
150


Example 129
10
30
Alpha lipoic acid
8
152


Example 130
10
30
Caffeine
10
150


Example 131
10
30
Tocopherol
8
152


Example 132
10
30
Docosahexaenoic
8
152





acid


Example 133
10
30
Eicosapentaenoic
8
152





acid


Example 134
10
30
Conjugated
8
152





linolenic acid


Example 135
10
30

Ginkgo biloba

4
156





leaf extract


Example 136
10
30
Red ginseng
4
156





extract


Example 137
10
30
Soybean extract
8
152


Example 138
10
30
Epigallocatechin
10
150





gallate









[Experimental Method for Evaluating Solubility and Dissolution Stability of Examples]


The poorly soluble/insoluble material was added to the solutions having two types of the natural polymer oligomers dissolved therein and mixed during the preparation of the oligomer composites encapsulating the poorly soluble/insoluble materials in Examples 1 to 138, and then precipitates were dried during centrifugation or filtration to measure weights of insoluble precipitates.


Oligomer composite powders encapsulating the poorly soluble/insoluble material prepared in Examples 1 to 138 were weighed and put into distilled water to make a volume of 100 ml, and aqueous solutions were then prepared by stirring for 30 minutes. The prepared aqueous solutions were put into centrifuge tubes, in which the weights thereof had been previously measured, and centrifuged. Filtrates were removed and the tubes were dried in a vacuum drier at 60° C. for five days, and amounts of precipitates were then measured by measuring weight changes and solubilities of the oligomer composites containing a poorly soluble/insoluble material with respect to water were calculated. The presence of precipitates were visually observed while centrifuged supernatants were stored at 4° C. for zero week, one week, two weeks, three weeks, and four weeks.


The result of improvements in the solubility of the poorly soluble/insoluble material and the presence of precipitates with respect to Examples are presented in Tables 7 to 9.
















TABLE 7








Input amount









of oligomer









composite








Precipitate
containing a








amount
poorly








during
soluble/insoluble
Precipitate






Poorly
preparation
material
amount






soluble/
of oligomer
during
during


Presence



insoluble
composite
redissolution
redissolution
Solubility
Storage
of


Example
material
(g)1)
(g)
(g)
(mg/ml)
period
precipitate2)







Example 1
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No



acid








Example 2
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No



acid








Example 3
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No



acid








Example 4
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No



acid








Example 5
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No



acid








Example 6
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No



acid








Example 7
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No



acid








Example 8
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No



acid








Example 9
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No



acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


10
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


11
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


12
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


13
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


14
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


15
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


16
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


17
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


18
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


19
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


20
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


21
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


22
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


23
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


24
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


25
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


26
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


27
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


28
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


29
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


30
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


31
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


32
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


33
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


34
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


35
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


36
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


37
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


38
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


39
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


40
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


41
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


42
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


43
acid






1)precipitate amount of a poorly soluble/insoluble material undissolved during the preparation of an oligomer composite containing a poorly soluble/insoluble material




2)after the storage period of 4 weeks at 4° C., observation of the presence of precipitate





















TABLE 8








Input amount









of oligomer









composite








Precipitate
containing a








amount
poorly








during
soluble/insoluble
Precipitate






Poorly
preparation
material
amount






soluble/
of oligomer
during
during


Presence



insoluble
composite
redissolution
redissolution
Solubility
Storage
of


Example
material
(g)1)
(g)
(g)
(mg/ml)
period
precipitate2)







Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


44
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


45
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


46
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


47
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


48
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


49
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


50
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


51
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


52
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


53
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


54
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


55
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


56
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


57
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


58
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


59
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


60
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


61
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


62
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


63
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


64
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


65
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


66
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


67
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


68
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


69
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


70
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


71
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


72
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


73
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


74
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


75
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


76
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


77
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


78
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


79
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


80
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


81
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


82
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


83
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


84
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


85
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


86
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


87
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


88
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


89
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


90
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


91
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


92
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


93
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


94
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


95
acid






1)precipitate amount of a poorly soluble/insoluble material undissolved during the preparation of an oligomer composite containing a poorly soluble/insoluble material




2)after the storage period of 4 weeks at 4° C., observation of the presence of precipitate





















TABLE 9








Input amount









of oligomer









composite








Precipitate
containing a








amount
poorly








during
soluble/insoluble
Precipitate






Poorly
preparation
material
amount






soluble/
of oligomer
during
during


Presence



insoluble
composite
redissolution
redissolution
Solubility
Storage
of


Example
material
(g)1)
(g)
(g)
(mg/ml)
period
precipitate2)







Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


96
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


97
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


98
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


99
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


100
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


101
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


102
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


103
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


104
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


105
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


106
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


107
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


108
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


109
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


110
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


111
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


112
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


113
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


114
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


115
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


116
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


117
acid








Example
Ellagic
0.03
2.0
0.0
20.0
4 weeks
No


118
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


119
acid








Example
Ellagic
0.04
2.0
0.0
20.0
4 weeks
No


120
acid








Example
Amentoflavone
0.03
2.0
0.0
20.0
4 weeks
No


121









Example
Diosmetin
0.05
2.0
0.0
20.0
4 weeks
No


122









Example
Berginin
0.05
5.0
0.0
50.0
4 weeks
No


123









Example
Univestin
0.06
4.0
0.0
40.0
4 weeks
No


124









Example
Apigenin
0.03
2.0
0.0
20.0
4 weeks
No


125









Example
Resveratrol
0.03
2.0
0.0
20.0
4 weeks
No


126









Example
Isoflavones
0.06
4.0
0.0
40.0
4 weeks
No


127









Example
Salicylic
0.01
5.0
0.0
50.0
4 weeks
No


128
acid








Example
Alpha
0.02
4.0
0.0
40.0
4 weeks
No


129
lipoic









acid








Example
Caffeine
0.00
5.0
0.0
50.0
4 weeks
No


130









Example
Tocopherol
0.01
4.0
0.0
40.0
4 weeks
No


131









Example
Docosahexaenoic
0.01
4.0
0.0
40.0
4 weeks
No


132
acid








Example
Eicosapentaenoic
0.01
4.0
0.0
40.0
4 weeks
No


133
acid








Example
Conjugated
0.01
4.0
0.0
40.0
4 weeks
No


134
linolenic









acid








Example
Ginkgobiloba
0.02
2.0
0.0
20.0
4 weeks
No


135
leaf









extract








Example
Red
0.03
2.0
0.0
20.0
4 weeks
No


136
ginseng









extract








Example
Soybean
0.03
4.0
0.0
40.0
4 weeks
No


137
extract








Example
Epigalloca
0.01
5.0
0.0
50.0
4 weeks
No


138
techin









gallate






1)precipitate amount of a poorly soluble/insoluble material undissolved during the preparation of an oligomer composite containing a poorly soluble/insoluble material




2)after the storage period of 4 weeks at 4° C., observation of the presence of precipitate







As shown in Tables 7 to 9, with respect to the examples using two types of the natural polymer oligomers, it may be understood that when the poorly soluble/insoluble materials were added to the oligomer composite solutions to be encapsulated and then precipitates were almost not generated during centrifugation of the reaction solutions, and most of the poorly soluble/insoluble materials were encapsulated in the oligomer composites.


Precipitates were not generated even in the case that the prepared natural polymer oligomer composite powders containing the poorly soluble/insoluble material were redissolved and centrifuged, and precipitation was not observed after storing of centrifuged supernatants at 4° C. for 4 weeks.


Thus, when the poorly soluble/insoluble materials were encapsulated through the formation of oligomer composites by using oligomers derived from two types of hydrophilic natural polymers, solubilities of the poorly soluble/insoluble materials may be improved and dissolution stability may be increased. Therefore, the poorly soluble/insoluble materials may not only be used as a functional raw material of cosmetics industry, but application thereof may also be extended to other industries (food and medicine, etc.) requiring solubilization of the poorly soluble/insoluble materials.


According to a method of solubilizing a poorly soluble/insoluble material through formation of an oligomer composite of the present invention, an oligomer structure having a hydrophobic cavity structure is formed by physical bonding between molecules and a poorly soluble/insoluble material is encapsulated in the oligomer structure. Thus, dissolution stability of the poorly soluble/insoluble material in an aqueous solution may be increased.


Also, since precipitation due to redissolution of the poorly soluble/insoluble materials is prevented, the oligomer composite encapsulating the poorly soluble/insoluble material has excellent dissolution stability, and inherent biological activity of the poorly soluble/insoluble material may also be maintained as it is, because a chemical reaction is not accompanied.


The foregoing oligomer composite encapsulating the poorly soluble/insoluble material may improve water solubility and dissolution stability of an active substance.


Since the oligomer composite encapsulating the poorly soluble/insoluble material thus prepared has excellent dissolution stability, the oligomer composite may not only be used as a functional raw material of cosmetics industry, but application thereof may also be extended to other industries (food and medicine, etc.) requiring solubilization of the poorly soluble/insoluble materials.


A method of solubilizing a poorly soluble/insoluble active material through formation of an oligomer composite according to embodiments will be described in detail with reference to the accompanying drawings. The invention may, however, be embodied in many different forms and should not be construed as being limited to the embodiments set forth herein; rather, that alternate embodiments included in other retrogressive inventions or falling within the spirit and scope of the present disclosure can easily be derived through adding, altering, and changing, and will fully convey the concept of the invention to those skilled in the art.

Claims
  • 1. A method of solubilizing a poorly soluble/insoluble active material through formation of an oligomer composite, the method comprising: a first operation of preparing an oligomer composite having a hydrophobic cavity structure formed therein by mixing and dissolving oligomers derived from two types of hydrophilic natural polymers in water;a second operation of adding a poorly soluble/insoluble material to the oligomer composite prepared in the first operation to encapsulate the poorly soluble/insoluble material in the hydrophobic cavity structure, of the oligomer composite, which is obtained in the first operation,a third operation of removing a residual poorly soluble/insoluble material unencapsulated in the oligomer composite by filtration or centrifugation of a reaction solution; anda fourth operation of removing water and an organic solvent (when used) from the reaction solution having the residual material removed therefrom to dry,wherein the oligomers derived from the natural polymers are two selected from the group consisting of xanthan gum, acacia gum, guar gum, arabic gum, agar, alginic acid, pectin, carboxyalkylcellulose, maltodextrin, and dextrin,wherein the poorly soluble/insoluble material is any one selected from the group consisting of:polyphenols, wherein the polyphenols are selected from the group consisting of amentoflavone, ellagic acid, apigenin, berginin, diosmetin, univestin, resveratrol, isoflavones, and catechin;oily fatty acids, wherein the fatty acids are selected from the group consisting of salicylic acid, alpha lipoic acid, caffeine, tocopherol, DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid), and CLA (conjugated linolenic acid); andnatural extracts containing a ginkgo biloba leaf extract, and a red ginseng extract.
  • 2. The method of claim 1, wherein a weight ratio of the natural polymer oligomers with respect to a total weight of a total solid content is in a range of about 1:1 to about 1:10, and the natural polymer oligomers are mixed within a temperature range of about 20° C. to about 80° C.
  • 3. The method of claim 1, wherein the poorly soluble/insoluble material is added in an amount range of about 0.1 wt % to about 99 wt % based on a total solid content and is mixed within a temperature range of about 20° C. to about 80° C.
  • 4. The method of claim 1, wherein the poorly soluble/insoluble material in the second operation is added by being dissolved in an organic solvent.
  • 5. The method of claim 4, wherein the organic solvent is any one selected from the group consisting of methanol, ethanol, acetone, THF (tetrahydrofuran), and AN (acetonitrile).
Priority Claims (1)
Number Date Country Kind
10-2009-0121886 Dec 2009 KR national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/KR2010/007066 10/15/2010 WO 00 4/30/2012
Publishing Document Publishing Date Country Kind
WO2011/071239 6/16/2011 WO A
US Referenced Citations (4)
Number Name Date Kind
20040228884 Gupta Nov 2004 A1
20060188578 Fernandez et al. Aug 2006 A1
20080102114 Koritala et al. May 2008 A1
20080160096 Berbely et al. Jul 2008 A1
Foreign Referenced Citations (1)
Number Date Country
1020060065585 Jun 2006 KR
Non-Patent Literature Citations (4)
Entry
Liu, Z et al, “Polysaccharides-based Nanoparticles as Drug Delivery Systems”, In: Adv. Drug Deliv. Rev. Sep. 17, 2008, vol. 60, pp. 1650-1662.
Cjem, Y. et al. “Chitosan-Dextran Surfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide.” In: Lett. Pept. Sci. 2003, vol. 10, pp. 621-629.
Cui, Z, et al. “Chitosan-based Nanoparticles for Topical Generic Immunization” In: J. Contr, Rel. 2001, vol. 75, pp. 409-419.
Ferreira, I et al, “Encapsulation of Antioxidants by Spray-Drying” In: Chem. Eng. Trans. 2007, vol. 11, pp. 713-717.
Related Publications (1)
Number Date Country
20120219604 A1 Aug 2012 US